Acadia Healthcare Company, Inc. is classed by the SEC under Services-Specialty Outpatient Facilities, NEC (industry code 8093), based in Franklin, TN. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $3.3 billion and a loss of $1.1 billion (its filed statements).
Usage businessServices-Specialty Outpatient Facilities, NECFranklin, TNfilings since 20119 of 9 filed
Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a usage business: prior from its industry code (SEC 8093, Services-Specialty Outpatient Facilities, NEC); the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.
The grade, in three tenses
Headline 4.1 out of ten, 9 of 9 metrics filed: past 5.0 out of ten, present 3.5 out of ten, future 3.8 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.
The nine metrics
Surviving crises (past): 7.3 out of ten. No warning events in its filings since 2017. 73rd percentile among 22 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Track record (past): 3.0 out of ten. +1.8% a year over 10 filed years; profitable in 6 of 10. 30th percentile among 22 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Shareholder treatment (past): 5.7 out of ten. Share count shrank 0.3% a year. 7% of cash flow returned. Insiders: 0 sales, 0 purchases. 57th percentile among 22 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Financial health (present): 4.5 out of ten. ROE -57%: lost 57¢ per shareholder dollar. Leverage 65%: owes 65¢ per asset dollar. 45th percentile among 22 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Industry position (present): 3.4 out of ten. bottom 34% of 22 in its family; net margin -33.3%. 34th percentile among 22 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Leadership (present): 2.3 out of ten. bottom 23% of 19 in its family for leadership; chief executive since 2026. 23rd percentile among 19 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-09).
Room to expand (future): 1.7 out of ten. bottom 17% of 22 in its family for room to expand. 17th percentile among 22 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Growth drivers (future): 7.3 out of ten. top 27% of 22 in its family for growth drivers. 73rd percentile among 22 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Expectations vs reality (future): 0.5 out of ten. bottom 5% of 22 in its family for expectations against reality. 5th percentile among 22 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
The filing record
Newest annual report: Form 10-K filed 2026-02-27 for the period ended 2025-12-31 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-07-28 for the period ended 2026-06-30 (on EDGAR). Newest results release: Form 8-K filed 2026-07-28 (on EDGAR). Newest filing: Form SCHEDULE 13G, 2026-10-08. Filings on record since 2011. Read from EDGAR 2026-10-12.
Who runs it
Osteen, Debra K (Chief Executive Officer); Duckworth, David M. (Interim CFO); Young, Todd S. (Chief Financial Officer); Sides, Timothy August (Interim CFO); Dixon, Heather Brianne (Chief Financial Officer); Khan, Nasser (Chief Operating Officer); Farley, Brian (EVP, CLAO and Secretary); Bernhard, Jason (director); Bissell, E. Perot (director); Cancelmi, Daniel J (director); and 6 more. 16 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-09-30.
Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.